| （単位：千ドル） | 3Q20 | 1Q21 | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 9,679 | 18,625 | 23,872 | 36,510 | 28,236 | 46,664 | 34,670 | 37,536 | 59,130 | 55,251 | 44,539 | 62,263 | 92,800 | 106,447 |
| 営業費用 | 13,520 | 25,134 | 30,165 | 42,766 | 35,783 | 52,755 | 42,279 | 45,464 | 66,736 | 62,273 | 69,157 | 71,962 | 105,659 | 122,372 |
| 営業利益 | -13,520 | -25,134 | -30,165 | -42,766 | -35,783 | -52,755 | -42,279 | -45,464 | -66,736 | -62,273 | -69,157 | -71,962 | -105,659 | -122,372 |
| 純利益 | -13,920 | -24,968 | -29,955 | -42,582 | -35,583 | -52,304 | -41,385 | -44,187 | -64,902 | -60,210 | -65,649 | -65,102 | -97,125 | -115,361 |
| 一株あたり利益 | - | - | - | - | - | -1.01 | -0.8 | -0.78 | -1.08 | -0.99 | -0.81 | -0.7 | -0.96 | -1.05 |
| 希薄化後一株あたり利益 | - | - | - | - | - | -1.01 | -0.8 | -0.78 | -1.08 | -0.99 | -0.81 | -0.7 | -0.96 | -1.05 |
| EBITDA |